期刊文献+

肺癌细胞表面CAR表达水平与腺病毒转基因治疗的可能性研究 被引量:2

CAR expression level on lung cancer cell surface and potential adenovirus mediated gene therapy
下载PDF
导出
摘要 目的:研究肺癌细胞表面柯萨奇腺病毒受体(CAR)表达水平与基因治疗的可能性。方法:用特异性CAR72抗体通过免疫组织化学Envision法在检测CAR在肺癌组织细胞中的表达水平。结果:在32例鳞癌中有25例CAR高表达、5例小细胞肺癌全部高表达,相反,CAR在22例腺癌中仅6例高水平表达。在非恶性肺泡上皮中为阴性。结论:以腺病毒血清型5为载体的基因治疗适合于鳞癌和非小细胞肺癌,而不适合于大多数腺癌。 Objective: To investigate the gene expression level of the Coxsackievirus and adenovirus receptor (CAR) locating on lung cancer cell surface and the potential strategy of gene therapy. Methods: Specific CAR72 antibody was used to detect CAR expression level in lung cancer cells of archived paraffin samples with the Envision immunohistochemical staining method. Results: High CAR expression were observed in five cases of small cell lung cancer , 25 of 32 pulmonary squamous cell carcinoma cases and only six of 22 lung adenocarcinoma. No CAR expression was detected in non - malignant alveolar epithelial. Conclusion: Gene therapy using adenovirus sera type 5 as the vector is suitable for treatment of pulmonary squamous cell carcinoma and non - small cell lung cancer but not for pulmonary adenocarcinoma.
出处 《现代肿瘤医学》 CAS 2008年第6期947-950,共4页 Journal of Modern Oncology
基金 江苏省社会发展资助项目(编号:BS2007025)
关键词 肺癌 CAR 基因治疗 lung cancer CAR gene therapy
  • 相关文献

参考文献11

  • 1Takahashi T. Lung cancer: an ever increasing store of indepth basic knowledge and the beginning of its clinical application[ J]. Oncogene ,2002, 21 ( 45 ) :6868 - 6869.
  • 2Toloza EM. Gene therapy for lung cancer[ J ]. Semin Thorac Cardiovasc Surg,2005, 17(3) :205 -212.
  • 3Rauen KA, Sudilovsky D, Le JL, et al. Expression of the coxsackie ademwirus receptor in normal prostate and in primary and metastatic prostate carcinoma: potential relevance to gene therapy [ J ]. Cancer Res,2002, 62(13) :3812 -3818.
  • 4Kay MA, Glorioso JC, Naldini L. Viral vectors tor gene therapy: the art of turning infectious agents into vehicles of therapeutics[ J ]. Nat Med ,2001,7( 1 ) :33 -40.
  • 5Roth JA, Swisher SG, Merritt JA, et al. Gene therapy for non - small cell lung cancer: a preliminary report of a phase Ⅰ trial of adenoviral p53 gene replacement [ J ]. Semin Oncol, 1998, 25 (3Suppl 8) :33 -37.
  • 6Nishizaki M, Meyn RE, Levy LB, et al. Synergistic inhibition of human lung cancer cell growth by adenovirus - mediated wild - type p53 gene transfer in combination with docetaxel and radiation therapeutics in vitro and in vivo [ J ]. Clin Cancer Res,2001, 7 (9) :2887 - 2897.
  • 7Inge T, Caroline M, Sven T, et al. Identification of alternative splice products encoded by the human coxsackie - adenovirus receptor gene [ J ]. Biochem and Biophis Rese Communication, 2001,287( 1 ) :216 -222.
  • 8Tomko RP, Johansson CB, Totrov M, et al. Expression of the adenovirus receptor and its interaction with the fiber knob [ J ]. Exp Cell Res ,2000 ,255 ( 1 ) :47 -55.
  • 9Michael A Seidman, Suzanne M Hogan, Rebecca L Wendland, et al. Variation in adenovirus receptor expression and adenovirus vector - mediated transgene expression at defined stages of the cell cycle[ J ]. Molecular Therapy, 2001,4( 1 ) : 13 - 21.
  • 10Min Qin, Shuang Chen, Tina Yu, ct al. Coxsackievirus adenovirus receptor expression predicts the efficiency of aqdenoviral gene transfer into non - small cell Lung cancer xenografts [ J ]. Clin Cancer Res ,2003,9:4992 - 4999.

同被引文献28

  • 1鞠丽梅,三好一郎,笠井憲雪,蔡有余.显微注射法制备转基因小鼠的技术研究[J].中国实验动物学报,1999,7(1):11-15. 被引量:9
  • 2Bruning A,Runnebaum IB.The coxsackie adenovirus receptor inhibits cancer cell migration[J].Exp cell Res,2004,298(2):624.
  • 3Rauen KA,Sudilovsky D,Le JL,et al.Expression of the coxsackie adenovirus receptor in normal prostate and in primary and metastatic prostate carcinoma:potential relevance to genetherapy[J].Cancer Res,2002,62(13):133812.
  • 4Douglas JI,Kim,Sumerel LA,et al.Efficient oncolysis by a replicating adenovirus(ad)in vivo is critically dependent on tumor expression of primary adreceptors[J].Cancer Res,2001,61(3):813.
  • 5Manabu Y,Asami I,Kenji K,et al.Expression of coxsackie and adenovirus receptor reduces the lung metastatic potential of murine tumor cells[J].Int J Cancer,2007,121:1690.
  • 6Glasgow JN,Bauerschmitz GJ,Curiel DT,et al.Transductional and transcriptional targeting of adenovirus for clinical applications[J].Curr Gene Ther,2004,4(1):1.
  • 7Okegawa T,Nutahara K,Pong RC,et al.Enhanced transgene expression in urothelial cancer gene therapy with histone deacetylase inhibitor[J].J Urol,2005,174(2):747.
  • 8Watanabe T,Hioki M,Fujiwara T,et al.Histone deacetylase inhibitor FR901228 enhances theantitumor effect of telomerase specific replication selective adenoviral agent OBP2301 in human lungcancer cells[J].Exp Cell Res,2006,312(3):256.
  • 9Krom YD,Gras JC,Frants RR,et al.Efficient targeting of adenoviral vectors to integrin positive vascular cells utilizing a CAR cyclicRGD linker protein[J].Biochem Biophys Res Commun,2005,338(2):847.
  • 10Krasnykh V,Dmitriev I,Navarro JG,et al.Advanced generation adenoviral vectors possess augmented gene transfer efficiency based upon coxsackie adenovirus receptor independent cellular entry capacity[J].Cancer Res,2000,60(4):578.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部